Treatment Options Post Exposure to COVID-19

Introductory content goes here…

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris placerat ullamcorper sem eu sodales. Praesent suscipit mauris nec augue bibendum, ut consequat massa sodales. Proin et lacus enim. Vivamus vulputate luctus ultrices. Quisque consequat porttitor fringilla. Mauris vitae nulla porttitor, gravida diam et, egestas mauris. Mauris convallis metus at urna rutrum, eget hendrerit metus porttitor. Maecenas posuere lorem rhoncus nisi eleifend mollis. 

Web Tip: This has the potential to change everything and give us freedom like that already enjoyed by those vaccinated who have a normal immune system.

CLL Society’s COVID-19 Update for the Week of November 28th, 2022

CLL Society’s COVID-19 Update for the Week of November 28th, 2022: Here is your weekly summary of what has been happening this past week in the United States. Keep in mind, data is always going to be delayed/underreported when there is a holiday weekend due to government offices being closed. But we are still going to provide the latest information available to us.

Many Patients with Weak Immune Systems Don’t Realize Their COVID-19 Medicine Isn’t as Effective as It Used to Be

CNN interviewed CLL Society’s Dr. Brian Koffman and Robyn Brumble, RN, among others, to gain perspective on the significance of the diminishing susceptibility of the emerging SARS-CoV-2 Variants of Concern (VOC) to Evusheld, the only Pre-Exposure Prophylaxis (PrEP) for the immunocompromised; including all those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).